Advances in the Medical Treatment of Diabetic Retinopathy  

Oleh:

Simo, Rafael ; Hernandez, Cristina

Jenis: Article from Journal - ilmiah internasional
Dalam koleksi: Diabetes Care vol. 32 no. 08 (Aug. 2009), page 1556-1562.
Topik: Diabetic Retinopathy

Ketersediaan

Perpustakaan FK Nomor Panggil: D05.K.2009.02 Non-tandon: 1 (dapat dipinjam: 0) Tandon: tidak ada

Lihat Detail Induk

Isi artikel

Proliferative diabetic retinopathy (PDR) remains the leading cause of blindness among working-age individuals in developed countries (1). Diabetic macular edema (DME), another important event that occurs in diabetic retinopathy, is more frequent in type 2 than type 1 diabetes (2). Whereas PDR is the most common sight-threatening lesion in type 1 diabetes, DME is the primary cause of poor visual acuity in type 2 diabetes. Because of the high prevalence of type 2 diabetes, DME is the main cause of visual impairment for diabetic patients (2). In addition, DME is almost invariably present when PDR is detected in type 2 diabetes (3). Neovascularization caused by severe hypoxia is the hallmark of PDR, whereas vascular leakage caused by the breakdown of the blood retinal barrier (BRB) is the main event involved in the pathogenesis of DME (4,5).

Opini Anda

Klik untuk menuliskan opini Anda tentang koleksi ini!

Kembali